Pharmaceuticals and Biotech Press Releases

An Independent Pharmacy's Recipe for Success: Combine Purchase Power With Billing Optimization

An Independent Pharmacy's Recipe for Success: Combine Purchase Power With Billing Optimization

For all independent pharmacy owners, success means you must have the right information and technology to compete. This translates to obtaining competitive drug pricing, combined with intelligent Real-Time Benefits Verification (iRTBV), which will put you in an optimal position to…

Presidential Orders Make Canada Pharmacy Shopping Easy for Everyone

Presidential Orders Make Canada Pharmacy Shopping Easy for Everyone

Huge changes are in store for millions of uninsured American families, seniors and individuals looking to save their hard-earned money on prescription medications. Canada Pharmacy is pleased to announce everyone will soon be able to receive their prescriptions much cheaper…

B&B Pharmaceuticals, Inc. Receives ISO 9001:2015 Certification

B&B Pharmaceuticals, Inc. Receives ISO 9001:2015 Certification

B&B Pharmaceuticals, Inc., a repackager and wholesaler of bulk raw chemicals, equipment, and supplies used in pharmaceutical compounding, is pleased to announce that the company has completed the International Organization for Standardization (ISO®) 9001:2015 certification for its Quality Management Systems…

Memgen Announces Addition of Leading Vaccine Expert to Scientific Advisory Board

Memgen Announces Addition of Leading Vaccine Expert to Scientific Advisory Board

Memgen, Inc., a private biotechnology company developing innovative immune-based drugs for the control of infectious diseases and cancer, announced today that Dr. Thomas Monath, a world-renowned virologist and vaccinologist, has joined the Company’s Scientific Advisory Board. The addition of Dr.…

APAC Biotech Awarded Patent for Maturation and Production of Dendritic Cells as a Personalized Immunotherapy Treatment for Cancer

APAC Biotech Awarded Patent for Maturation and Production of Dendritic Cells as a Personalized Immunotherapy Treatment for Cancer

APAC Biotech, an Indian biotechnology company involved in extensive research on personalized immunotherapy using dendritic cells for over a decade, was finally granted Indian patent (340947), entitled “COMPOSITION AND METHOD FOR PRODUCING ACTIVATED DENDRITIC CELLS”. The company has previously conducted…

Bioz Has Partnered With New England Biolabs to Empower Life Science Researchers Around COVID-19 Discovery

Bioz Has Partnered With New England Biolabs to Empower Life Science Researchers Around COVID-19 Discovery

Bioz, Inc., a Silicon Valley software AI company, and New England Biolabs® (NEB®), a world leader in the discovery and production of enzymes for molecular biology applications, today announce the launch of a new stand-alone Bioz Search Tool to guide…

Consumer51 Launches Brand Identity and Website for World’s First Adaptive Wheelchair SideKick™

Consumer51 Launches Brand Identity and Website for World’s First Adaptive Wheelchair SideKick™

Consumer51, a global consumer-experience company launched the brand identity and new website for the world's first adaptive all-in-one wheelchair assistant named SideKick™.The SideKick™ is a unique product created as a modular system to give wheelchair users independence and autonomy, whether…

Dante Labs IMMENSA Receives CE-IVD Mark for Whole Genome Data Interpretation Based on Study of Over 150,000 Cases

Dante Labs IMMENSA Receives CE-IVD Mark for Whole Genome Data Interpretation Based on Study of Over 150,000 Cases

Dante Labs received CE-IVD Mark for its IMMENSA Software for interpretation of whole genome sequencing data in a clinical setting at scale. IMMENSA was built leveraging more than 150,000 genomic reports generated by Dante Labs for its users and patients…

TALLC Corporation Announces Grant of New SmartCelle Patent for Enhanced Ocular Delivery of TA-A001

TALLC Corporation Announces Grant of New SmartCelle Patent for Enhanced Ocular Delivery of TA-A001

TALLC Corporation Inc. (TALLC) a pioneering pharmaceutical company using proprietary new molecular entities to treat acute and chronic inflammation today announced that the United Kingdom Intellectual Property Office (IPO) has granted TALLC patent GB2561009, entitled “Non-ionic Block Copolymers and Pharmaceutical…

CaaMTech Synthesizes Novel Tryptamine Prophoria™, Amphoria™

CaaMTech Synthesizes Novel Tryptamine Prophoria™, Amphoria™

CaaMTech, Inc. announced today that CaaMTech scientists have synthesized two important tryptamines for the very first time: Amphoria™ (4-HO-TMT), and Prophoria™ (4-AcO-TMT). Reported in ACS Omega, CaaMTech’s groundbreaking research paves the way for a significantly improved scientific understanding of the…

AirAnswersTM Confirms Airborne COVID-19 in Breakthrough Collaborative Study With the University of Chicago

AirAnswersTM Confirms Airborne COVID-19 in Breakthrough Collaborative Study With the University of Chicago

Inspirotec, Inc. is the only company providing airborne allergen detection either through physicians, industrial hygienists, indoor air quality professionals, home resale, or direct to consumer. It has developed a highly sensitive patented technology for testing and measuring biological agents in…

Two Specialty GPOs Create a Partnership to Leverage Collective Buying Power for Brand and Generic Drugs for Independent Pharmacies

Two group purchasing organizations (GPOs) have united to form a unique partnership that will open new channels of distribution for independent pharmacies and lower costs across the nation. As of July 1, DermSource, a dermatology GPO in New Hyde Park, New…

LayerBio Awarded $3M From U.S. Department of Defense (DoD) to Advance OcuRing™ for Cataract Surgery

LayerBio Awarded $3M From U.S. Department of Defense (DoD) to Advance OcuRing™ for Cataract Surgery

OcuRing™ is a novel sustained-release technology designed to deliver therapies to cataract surgery patients, potentially eliminating the need for postoperative topical drops. The drug eluting device is attached to an intraocular lens (IOL) for implantation during cataract surgery.  Because of its…

New Talent on Board at MedEvoke

New Talent on Board at MedEvoke

During this challenging time, MedEvoke is in a unique position to strengthen as an industry leader in global alignment, focusing on developing scientifically compelling narratives and digitally oriented solutions that unify communications and support collaboration to meet the expanding needs…

Philogen Received Clinical Trial Authorisation With Nidlegy in Nonmelanoma Skin Cancer

Philogen Received Clinical Trial Authorisation With Nidlegy in Nonmelanoma Skin Cancer

Philogen S.p.A., a privately-owned biotechnology company, is pleased to announce that the Swiss national competent authority Swissmedic issued the authorization to run a clinical phase II study in patients with locally advanced, not metastatic nonmelanoma skin cancer. A favorable opinion about…

Philogen Received Combination Pack Approval for Nidlegy

Philogen Received Combination Pack Approval for Nidlegy

Philogen S.p.A., a privately-owned biotechnology company, is pleased to announce that, on Jan. 30, 2020, EMA's CHMP expressed a favorable opinion to the request of a combination pack for the to-be-marketed pharmaceutical form of NidlegyTM, a combination of the active principles…

Immunovative Therapies and Mirror Biologics Announce US FDA Clearance of a Universal Anti-Viral Vaccine Phase I/II Clinical Trial  for Healthy Elderly Adults

Immunovative Therapies and Mirror Biologics Announce US FDA Clearance of a Universal Anti-Viral Vaccine Phase I/II Clinical Trial for Healthy Elderly Adults

Mirror Biologics, Inc. (Phoenix, AZ), the commercial development arm of Immunovative Therapies, Ltd. (Jerusalem, IL) (together “the Company”), a clinical-stage company specialized in the development, manufacturing and clinical translation of next-generation immunotherapy drugs where the active ingredients are living immune cells,…

Gemini Bio Opens New cGMP Facility

Gemini Bio Opens New cGMP Facility

Gemini Bioproducts, LLC (“Gemini Bio”), a leading supplier of cell culture reagents and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, today announced the opening of a new, state-of-the-art manufacturing facility in…

Insight Partners Invests in Apprentice.io to Scale Its Intelligent Software Platform During COVID-19 to Help Life Science Companies Meet Market Demands

Insight Partners Invests in Apprentice.io to Scale Its Intelligent Software Platform During COVID-19 to Help Life Science Companies Meet Market Demands

Intelligent software company for life science manufacturing Apprentice.io welcomes new investors to scale its solutions that steady pharma supply chains and get critical drugs to market in the wake of COVID-19. As the novel coronavirus became a global pandemic, travel restrictions, site…

Hoy Health, LLC Launches First Bilingual Telemedicine + Medication Program HoyDoc+

Hoy Health, LLC Launches First Bilingual Telemedicine + Medication Program HoyDoc+

​​Hoy Health, LLC announced today the launch of HoyDoc+, the first fully Spanish and English language telemedicine program offering consumers convenient, affordable access to doctor consultations and a one month supply of medication from a selection of over 600 prescription drugs,…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login